Concepedia

Jennifer L. Taylor‐Cousar

JL

62

Publications

8.1K

Citations

34

H-Index

2007

Active since

Affiliations

University of Colorado Denver(Current)

National Jewish Health

University of Washington

University of Alabama at Birmingham

Vertex Pharmaceuticals (United States)

Jennifer L. Taylor‐Cousar is an author at University of Colorado Denver specializing in medicine, pulmonary fibrosis, and obstetrics.

ORCID

Top concepts

Publications per year

2007–2025

62

Publications

62

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Peter G. Middleton, Marcus Mall, Pavel Dřevı́nek et al. · New England Journal of Medicine · 2019 · 2K citations · Full text

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.3K citations · Full text

, , +2

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

Jennifer L. Taylor‐Cousar, À. Munck, Edward F. McKone et al. · New England Journal of Medicine · 2017 · 765 citations · Full text

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

D. Keating, Gautham Marigowda, Lucy Burr et al. · New England Journal of Medicine · 2018 · 707 citations · Full text

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

Jane C. Davies, Samuel M. Moskowitz, Cynthia D. Brown et al. · New England Journal of Medicine · 2018 · 320 citations · Full text

Rows per page

1–5 of 62